sarsasapogenin has been researched along with Disease Models, Animal in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (28.57) | 29.6817 |
| 2010's | 3 (42.86) | 24.3611 |
| 2020's | 2 (28.57) | 2.80 |
| Authors | Studies |
|---|---|
| Fan, L; Shi, J; Song, C; Wang, H; Wang, J; Yang, S; Zhang, P; Zhang, R; Zhang, Y | 1 |
| Cui, SC; Huang, CG; Jiang, HW; Li, J; Li, JY; Li, YF; Ma, HJ; Xie, ZF; Yu, YY; Zheng, TN; Zhu, KX | 1 |
| Dong, D; Huang, C; Jiao, Q; Ma, L; Pan, H; Wang, R | 1 |
| Chen, Q; Jin, L; Li, J; Liu, J; Wang, T; Wang, W; Yu, H; Zhang, Y | 1 |
| Hu, Y; Orsi, A; Rees, D; Wang, Z; Wu, P; Xia, Z; Zhang, R | 1 |
| Hu, Y; Orsi, A; Rees, D; Sun, Q; Xia, Z | 1 |
| Brotchie, JM; Callizot, N; Dixon, K; Howson, PA; Johnston, TH; Orsi, A; Rees, DD; Visanji, NP | 1 |
7 other study(ies) available for sarsasapogenin and Disease Models, Animal
| Article | Year |
|---|---|
Smilagenin induces expression and epigenetic remodeling of BDNF in alzheimer's disease.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Animals; Brain-Derived Neurotrophic Factor; Disease Models, Animal; Epigenesis, Genetic; Hippocampus; Histones; Humans; Mice; Mice, Transgenic; Neuroblastoma | 2023 |
Sarsasapogenin improves adipose tissue inflammation and ameliorates insulin resistance in high-fat diet-fed C57BL/6J mice.
Topics: 3T3-L1 Cells; Adipocytes; Adipose Tissue; Animals; Anti-Inflammatory Agents; Diet, High-Fat; Disease Models, Animal; Inflammation; Insulin Resistance; Macrophages; Male; Mice; Mice, Inbred C57BL; Mice, Obese; Obesity; RAW 264.7 Cells; Spirostans | 2021 |
Sarsasapogenin-AA13 ameliorates Aβ-induced cognitive deficits via improving neuroglial capacity on Aβ clearance and antiinflammation.
Topics: Amyloid beta-Peptides; Analysis of Variance; Animals; Animals, Newborn; Cells, Cultured; Cerebral Cortex; Cognition Disorders; Disease Models, Animal; Dose-Response Relationship, Drug; Injections, Intraventricular; Male; Maze Learning; Mice; Mice, Inbred ICR; Neuroglia; Peptide Fragments; Phagocytosis; Spirostans; Time Factors | 2017 |
Effect and mechanism of dioscin from Dioscorea spongiosa on uric acid excretion in animal model of hyperuricemia.
Topics: Adenine; Animals; Biomarkers; Creatinine; Dioscorea; Diosgenin; Disease Models, Animal; Dose-Response Relationship, Drug; Glucose Transport Proteins, Facilitative; HCT116 Cells; Humans; Hyperuricemia; Intestinal Elimination; Intestinal Mucosa; Intestines; Male; Mice; Organic Anion Transport Protein 1; Organic Anion Transporters; Organic Cation Transport Proteins; Oxonic Acid; Phytotherapy; Plant Extracts; Plants, Medicinal; Rats, Sprague-Dawley; Renal Elimination; Spirostans; Time Factors; Uric Acid; Uricosuric Agents | 2018 |
Regulation of M1-receptor mRNA stability by smilagenin and its significance in improving memory of aged rats.
Topics: 3,3'-Diaminobenzidine; Aging; Analysis of Variance; Animals; Atropine; Binding Sites; Binding, Competitive; Brain; CHO Cells; Cholinesterase Inhibitors; Cholinesterases; Cricetinae; Cricetulus; Disease Models, Animal; Dose-Response Relationship, Drug; Gene Expression Regulation; Maze Learning; Memory Disorders; Muscarinic Antagonists; Rats; Rats, Sprague-Dawley; Receptor, Muscarinic M1; RNA, Messenger; Spirostans; Tacrine; Transfection; Tritium | 2010 |
A new approach to the pharmacological regulation of memory: Sarsasapogenin improves memory by elevating the low muscarinic acetylcholine receptor density in brains of memory-deficit rat models.
Topics: Acetylcholinesterase; Age Factors; Amyloid beta-Peptides; Animals; Autoradiography; Brain; Disease Models, Animal; Excitatory Amino Acid Agonists; Female; Ibotenic Acid; Immunohistochemistry; Male; Maze Learning; Memory Disorders; Nerve Degeneration; Neurotoxins; Peptide Fragments; Rats; Rats, Sprague-Dawley; Receptors, Muscarinic; Spirostans | 2005 |
PYM50028, a novel, orally active, nonpeptide neurotrophic factor inducer, prevents and reverses neuronal damage induced by MPP+ in mesencephalic neurons and by MPTP in a mouse model of Parkinson's disease.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Administration, Oral; Animals; Disease Models, Animal; Glial Cell Line-Derived Neurotrophic Factor; Male; Mesencephalon; Mice; Nerve Growth Factors; Neurons; Neurotoxins; Parkinsonian Disorders; Rats; Spirostans; Tyrosine 3-Monooxygenase | 2008 |